Interferon-γ, Interleukin 1-β and Tumor Necrosis Factor-α levels and Their Association with Lipid and Glycaemic Profiles in Diabetic Mice
International Journal of Biochemistry Research & Review,
The cytokines IFN-γ, interleukin IL-1β, and TNF-α each up regulate the expression of major histocompatibility complex (MHC) and are therefore considered as inflammatory markers. The present study aimed to measure the serum levels of IFN-γ, interleukin IL-1β, and TNF-α in mice after induction of diabetes with streptozotocin and to correlate their levels to lipid and glycaemic profiles. The study included 40 Swiss Albino mice (20 males and 20 females), half of each male and female groups were made diabetic by intraperitoneal injection of streptozotocin. After 48 hours, the serum levels of INF-γ, IL1-β as well as TNF-α were measured with ELISA and their levels were correlated to lipid and glycaemic profiles. The levels of the cytokines, IFN-γ, IL1-β and TNF-α were measured and correlated to lipid profile, blood glucose and insulin. The serum levels of the three studied cytokines, IFN-γ, IL 1-β and TNF-α were statistically significantly higher among diabetic mice compared to the control group. Diabetic male mice (M-STZ mice) group showed significantly higher lipid profile compared to the control group (M-control). Cholesterol level was significantly higher among female control (F-control) compared to the M-control group. Cholesterol level was significantly higher among diabetic female mice (F-STZ mice) compared to the F-Control group. Regarding IFN-γ, IL 1-β and TNF-α levels, there were significant linear correlations with the glycemic profile (Glucose, insulin) reflected as positive correlation with blood glucose level and negative correlation with insulin level.
- diabetic mice
How to Cite
Chatzigeorgiou A, Harokopos V, Mylona-Karagianni C, Tsouvalas E, Aidinis V, and Kamper E. The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time. Ann. Med. 2010;42:426–438.
Rabinovitch A, and Suarez-Pinzon WL. Roles of cytokines in the pathogenesis and therapy of type 1 diabetes. Cell Biochem. Biophys. 2007;48:159–163.
Dinarello CA, van der Meer JWM. Treating inflammation by blocking interleukin-1 in humans. Semin. Immunol. 2013;25:469–484.
Mandrup-Poulsen T, Pickersgill L, and Donath MY. Blockade of interleukin 1 in type 1 diabetes mellitus. Nat. Rev. Endocrinol. 2010;6:158–166.
Thomas HE, Irawaty W, Darwiche R, Brodnicki TC, Santamaria P, Allison J, and Kay TWH. IL-1 Receptor Deficiency Slows Progression to Diabetes in the NOD Mouse. Diabetes. 2004;53: 113–121.
Sumpter KM, Adhikari S, Grishman EK, and White PC. Preliminary studies related to anti-interleukin-1β therapy in children with newly diagnosed type 1 diabetes. Pediatr. Diabetes. 2011;12:656–667.
Kaizer EC, Glaser CL, Chaussabel D, Banchereau J, Pascual V, and White PC. Gene Expression in Peripheral Blood Mononuclear Cells from Children with Diabetes. J. Clin. Endocrinol. Metab. 2007;92:3705–3711.
Lee L-F, Xu B, Michie SA, Beilhack GF, Warganich T, Turley S, and McDevitt HO. The role of TNF-alpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: Analysis of dendritic cell maturation. Proc. Natl. Acad. Sci. U. S. A. 2005;102:15995–6000.
Lechleitner M, Koch T, Herold M, Dzien A, and Hoppichler F. Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. J. Internal. Medicine. 2000;248: 67–76.
Bardini G, Rotella CM, Giannini S. Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and beta-cell dysfunction on micro- and macrovascular complications. Rev Diabet Stud. 2012;9:82–93. Wu L, Parhofer KG. Diabetic dyslipidemia. Metabolism. 2014;63:1469–79.
Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AA, Feldman EL. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes. 2009;58: 1634–40.
Han, Xue, et al. Metformin ameliorates insulitis in STZ-induced diabetic mice. Peer J 5. 2017; e3155.
Atkinson A, Eisenbarth S. Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet. 2001;358:221–229.
Bluestone, A, Herold, K, Eisenbarth, G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature. 2010;464:1293–1300.
Karvonen, M, Viik-Kajander, M, Moltchanova, E, Libman, I, LaPorte, R., Tuomilehto, J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care. 2000;23:1516–1526.
Gale A. Type 1 diabetes in the young: The harvest of sorrow goes on. Diabetologia. 2005;48:1435–1438.
Sun Chengxin, et al. Effect of fasting time on measuring mouse blood glucose level. Int. J, Clin. Exp, Mecl. 2016;4186-4189.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37 Suppl 1:S81-90.
Standards of medical care in diabetes. Summary of revisions. Diabetes care. 2015;38 Suppl. S4.
Van der Staay FJ, Arndt SS, Nordquist RE. Evaluation of animal models of neurobehavioral disorders. Behav Brain Funct March. 2009;5:11-33.
Eschenbach P and Dütting ED. Efficacy of vildagliptin and sitagliptin in lowering fasting plasma glucose: Results of a randomized controlled trial. Diabetes Metab. 2015;41:244-247.
Pozzilli, P., Guglielmi, C. Double diabetes: A mixture of type 1 and type 2 diabetes in youth. Endocrine Development. 2009;14: 151- 66.
Banerjee M, Saxena M. Genetic polymer-phisms of cytokine genes in type 2 diabetes mellitus. World Journal Diabetes. 2014;5:493–504
Chengxin Sun, Xinzhi Li, Lu Liu, Mark J Canet, Yuan Guan, Yuying Fan, Yifa Zhou. Effect of fasting time on measuring mouse blood glucose level. Int J Clin Exp Med. 2016;9(2):4186-4189.
Hitoshi Ando, Kentaro Ushijima, Shigeki Shimba, and Akio Fujimura. Daily Fasting Blood Glucose Rhythm in Male Mice. A Role of the Circadian Clock in the Liver Endocrinology. February 2016;157(2):463– 469.
Al Ghamdi A, Badr G, Hozzein W, Allam A, Al-Waili N, Al-Wadaan M, Garraud O. Oral supplementation of diabetic mice with propolis restores the proliferation capacity and chemotaxis of B and T lymphocytes towards CCL21 and CXCL12 by modulating the lipid profile, the pro-inflammatory cytokine levels and oxidative stress. BMC Immunology. 2015;16:54.
Gamal, A, Alsulaimani, A, Alghamdi, H, Alswat, H, Edrees, B, Ahmad, I, and Nasr, A, .Changes in the Levels of Cytokines in Both Diabetic/Non-Diabetic Type I Children Living in a Moderate Altitude Area in Saudi Arabia High Alt Med Biol. 2014;15(3):380–387.
Kamil et al. Triglyceride-to-high-density lipoprotein cholesterol ratio and systemic inflammation in patients with idiopathic pulmonary arterial hypertension. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2019;25:746.
Abstract View: 21 times
PDF Download: 9 times